Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mikhail Kolonin
University of Texas, Austin, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Astrotide, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Individual is co-founder, owns equity, and serves as a scientific advisor for Astrotide, Inc. Individuals receives compensation for advising. Individual is an inventor of University of Texas Health Science Center at Houston-owned intellectual property that is licensed to the entity and this technology will be used and improved upon in the research project.
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
A number of studies indicate that dietary energy balance plays a significant role in prostate cancer (PCa) as well as many other cancers. In particular, obesity is associated with more aggressive disease and increased mortality from PCa. The innovative concept pursued in this application is that white adipose tissue-derived cells, as a component of the tumor microenvironment, produce local factors (and especially the chemokine CXCL12) that play an important role in obesity-driven PCa progression. Completion of this project will provide the basis for future translational studies targeting specific signaling pathwas and/or cell populations to reduce PCa mortality and prevent the effects of obesity on PCa progression.
Filed on March 07, 2016.
Tell us what you know about Mikhail Kolonin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Mikhail Kolonin filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mikhail Kolonin | University of Texas, Austin | Conflict of Interest | Astrotide, Inc. | $0 - $4,999 |
| Mikhail Kolonin | University of Texas, Austin | Conflict of Interest | Astrotide, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.